164 related articles for article (PubMed ID: 21865343)
21. Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling.
Dielschneider RF; Xiao W; Yoon JY; Noh E; Banerji V; Li H; Marshall AJ; Johnston JB; Gibson SB
Cell Death Dis; 2014 Oct; 5(10):e1439. PubMed ID: 25275600
[TBL] [Abstract][Full Text] [Related]
22. Developmental stage-specific shift in responsiveness to chemokines during human B-cell development.
Honczarenko M; Glodek AM; Swierkowski M; Na IK; Silberstein LE
Exp Hematol; 2006 Aug; 34(8):1093-100. PubMed ID: 16863916
[TBL] [Abstract][Full Text] [Related]
23. CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1.
Shi M; Chen D; Yang D; Liu XY
J Exp Clin Cancer Res; 2015 Dec; 34():149. PubMed ID: 26667143
[TBL] [Abstract][Full Text] [Related]
24. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
[TBL] [Abstract][Full Text] [Related]
25. Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells.
Efremov DG; Gobessi S; Longo PG
Autoimmun Rev; 2007 Dec; 7(2):102-8. PubMed ID: 18035318
[TBL] [Abstract][Full Text] [Related]
26. Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia.
Ten Hacken E; Sivina M; Kim E; O'Brien S; Wierda WG; Ferrajoli A; Estrov Z; Keating MJ; Oellerich T; Scielzo C; Ghia P; Caligaris-Cappio F; Burger JA
J Immunol; 2016 Sep; 197(6):2522-31. PubMed ID: 27534555
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
Purroy N; Carabia J; Abrisqueta P; Egia L; Aguiló M; Carpio C; Palacio C; Crespo M; Bosch F
Oncotarget; 2017 Jan; 8(1):742-756. PubMed ID: 27888629
[TBL] [Abstract][Full Text] [Related]
28. MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.
Klasen C; Ohl K; Sternkopf M; Shachar I; Schmitz C; Heussen N; Hobeika E; Levit-Zerdoun E; Tenbrock K; Reth M; Bernhagen J; El Bounkari O
J Immunol; 2014 Jun; 192(11):5273-84. PubMed ID: 24760155
[TBL] [Abstract][Full Text] [Related]
29. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.
Cutrona G; Colombo M; Matis S; Fabbi M; Spriano M; Callea V; Vigna E; Gentile M; Zupo S; Chiorazzi N; Morabito F; Ferrarini M
Haematologica; 2008 Mar; 93(3):413-22. PubMed ID: 18287138
[TBL] [Abstract][Full Text] [Related]
30. Signaling through L-selectin mediates enhanced chemotaxis of lymphocyte subsets to secondary lymphoid tissue chemokine.
Subramanian H; Grailer JJ; Ohlrich KC; Rymaszewski AL; Loppnow JJ; Kodera M; Conway RM; Steeber DA
J Immunol; 2012 Apr; 188(7):3223-36. PubMed ID: 22387549
[TBL] [Abstract][Full Text] [Related]
31. Differential expression and function of CD27 in chronic lymphocytic leukemia cells expressing ZAP-70.
Lafarge ST; Hou S; Pauls SD; Johnston JB; Gibson SB; Marshall AJ
Leuk Res; 2015 Jul; 39(7):773-8. PubMed ID: 26002513
[TBL] [Abstract][Full Text] [Related]
32. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.
Jørgensen AS; Larsen O; Uetz-von Allmen E; Lückmann M; Legler DF; Frimurer TM; Veldkamp CT; Hjortø GM; Rosenkilde MM
Front Immunol; 2019; 10():2156. PubMed ID: 31572374
[TBL] [Abstract][Full Text] [Related]
33. The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C.
Bonacchi A; Petrai I; Defranco RM; Lazzeri E; Annunziato F; Efsen E; Cosmi L; Romagnani P; Milani S; Failli P; Batignani G; Liotta F; Laffi G; Pinzani M; Gentilini P; Marra F
Gastroenterology; 2003 Oct; 125(4):1060-76. PubMed ID: 14517790
[TBL] [Abstract][Full Text] [Related]
34. The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes.
Till KJ; Lin K; Zuzel M; Cawley JC
Blood; 2002 Apr; 99(8):2977-84. PubMed ID: 11929789
[TBL] [Abstract][Full Text] [Related]
35. iNKT cells with high PLZF expression are recruited into the lung via CCL21-CCR7 signaling to facilitate the development of asthma tolerance in mice.
Feng X; Zhao C; Li L; Feng J; He W; Shi T; Li N; Jie Z; Su X
Eur J Immunol; 2021 Feb; 51(2):414-432. PubMed ID: 32712954
[TBL] [Abstract][Full Text] [Related]
36. PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia.
Hu C; Xiong J; Zhang L; Huang B; Zhang Q; Li Q; Yang M; Wu Y; Wu Q; Shen Q; Gao Q; Zhang K; Sun Z; Liu J; Jin Y; Tan J
Cell Mol Immunol; 2004 Aug; 1(4):280-94. PubMed ID: 16225771
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
[TBL] [Abstract][Full Text] [Related]
38. Correlation between ZAP-70, phospho-ZAP-70, and phospho-Syk expression in leukemic cells from patients with CLL.
Kaplan D; Meyerson HJ; Li X; Drasny C; Liu F; Costaldi M; Barr P; Lazarus HM
Cytometry B Clin Cytom; 2010 Mar; 78(2):115-22. PubMed ID: 20014315
[TBL] [Abstract][Full Text] [Related]
39. B lymphocytes in humans express ZAP-70 when activated in vivo.
Cutrona G; Colombo M; Matis S; Reverberi D; Dono M; Tarantino V; Chiorazzi N; Ferrarini M
Eur J Immunol; 2006 Mar; 36(3):558-69. PubMed ID: 16482508
[TBL] [Abstract][Full Text] [Related]
40. TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis.
Pang MF; Georgoudaki AM; Lambut L; Johansson J; Tabor V; Hagikura K; Jin Y; Jansson M; Alexander JS; Nelson CM; Jakobsson L; Betsholtz C; Sund M; Karlsson MC; Fuxe J
Oncogene; 2016 Feb; 35(6):748-60. PubMed ID: 25961925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
